Bright Minds Biosciences annual stock-based compensation
2020
2021
2022
2023
2024
2025
Bright Minds Biosciences Stock-Based Compensation Growth & History (DRUG)
Bright Minds Biosciences's stock-based compensation was $3.2M for fiscal 2025.
View full Bright Minds Biosciences company overviewBright Minds Biosciences annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $3.2M | $2.3M | +279.00% |
| 2024 | 2024-09-30 | $839,771 | −$312,360 | −27.11% |
| 2023 | 2023-09-30 | $1.2M | $277,075 | +31.66% |
| 2022 | 2022-09-30 | $875,056 | −$5,559 | −0.63% |
| 2021 | 2021-09-30 | $880,615 | $719,315 | +445.95% |
| 2020 | 2020-09-30 | $161,300 | — | — |
Bright Minds Biosciences quarterly stock-based compensation
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | $1.5M | $227,519 | +17.22% |
| Q2 2026 | 2026-03-31 | $1.2M | $589,064 | +95.64% |
| Q1 2026 | 2025-12-31 | $1.3M | — | — |
| Q4 2025 | 2025-09-30 | $1.1M | — | — |
| Q3 2025 | 2025-06-30 | $1.3M | — | — |
| Q2 2025 | 2025-03-31 | $615,908 | — | — |
Bright Minds Biosciences stock-based compensation trends
Over the last five fiscal years, Bright Minds Biosciences's stock-based compensation increased from $161,300 to $3.2M, a change of $3.0M. The latest reported quarter, Q3 2026, shows $1.5M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bright Minds Biosciences source filings ↗